Question of the Day

Question of the Day – Monday October 15, 2018

Question -Hydroxyurea (hydrooxycarbamide) is an antineoplastic drug sometimes used in the treatment of myeloproliferative disorders as well as in a variety of malignancies. The most common toxicities attributed to the use of this drug include bone marrow failure and associated pancytopenia. What are the potential pulmonary toxicities associate with the use of this drug?

View full post for answer.

Question 1-Hydroxyurea (hydrooxycarbamide) is an antineoplastic drug sometimes used in the treatment of myeloproliferative disorders as well as in a variety of malignancies. The most common toxicities attributed to the use of this drug include bone marrow failure and associated pancytopenia. What are the potential pulmonary toxicities associate with the use of this drug?